Fable Therapeutics
- Business Model
- B2B
- Website
- fabletherapeutics.com
- Last Round
- SeedOct 2024
- Rounds
- 2
About
Biotech company applying machine learning to protein design for metabolic disease treatment.
Summary
Fable Therapeutics is an Artificial Intelligence company. Its most recent funding was a Seed round in Oct 2024. Investors include Omega Funds, Jerel Davis and DCVC (Data Collab).
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...